SPDR S&P Pharmaceuticals ETF
XPH
XPH
80 hedge funds and large institutions have $185M invested in SPDR S&P Pharmaceuticals ETF in 2019 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 18 increasing their positions, 21 reducing their positions, and 16 closing their positions.
Holders
80
Holders Change
+6
Holders Change %
+8.11%
% of All Funds
1.73%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
22
Increased
18
Reduced
21
Closed
16
Calls
$981K
Puts
–
Net Calls
+$981K
Net Calls Change
+$395K
Top Buyers
1 |
CS
1
Credit Suisse
Zurich,
Switzerland
|
$53.7M |
2 |
2
Barclays
London,
United Kingdom
|
$8.21M |
3 |
CI
3
Cavalier Investments
Alpharetta,
Georgia
|
$2.3M |
4 |
4
Envestnet Asset Management
Chicago,
Illinois
|
$1.49M |
5 |
5
Jane Street
New York
|
$1.32M |